Bradley I. Goetz et al. reply:
We recently proposed that nitrite-mediated vasodilation involves a reaction between NO and nitrite-bound methemoglobin, Hb(Fe(iii))-NO2−, to form N2O3, thus facilitating export of NO activity from the red blood cell1.
Schwab et al. challenge our recent work by suggesting that the nitrite binding affinity to methemoglobin is very low and that nitrite is not a physiological vasodilator. We maintain that (i) numerous studies now confirm that dietary, physiological and pharmacological levels of nitrite vasodilate and mediate hypoxic NO signaling2,3,4,5,6,7,8,9,10,11 and (ii) the binding of nitrite to methemoglobin is complex and includes an O-bound nitrito species that has NO2 radical character, and the affinity is high under certain conditions. This hypothesis was proposed based on a number of experimental observations, including rapid reductive nitrosylation, gas-phase N2O3 formation, density functional theory (DFT)calculations and evidence of an unusual electronic configuration of nitrite bound to methemoglobin measured by EPR spectroscopy. The formation of an O-bound nitrito species has now been independently confirmed by other groups using DFT calculations and X-ray crystallography12.
Schwab et al. challenge our proposed mechanism based on their calculation of a lower affinity of nitrite for methemoglobin. We propose that the difference between our results and theirs is due to experimental conditions used. Support for a low dissociation constant and the effects of experimental conditions is given in Figure 1, which provides evidence for complex behavior of the nitrite-methemoglobin interaction where both pH and other buffer conditions modulate affinity. Schwab et al. argue that our error in determining the dissociation constant was due to a failure to observe a low-spin nitrite-bound methemoglobin EPR signal. However, this does not affect our calculation of the dissociation constant, as we measured the disappearance of the high-spin methemoglobin signal as an indicator of the formation of nitrite–methemoglobin. We have found that at least part of the reason that we did not observe the low-spin nitrite–methemoglobin signal is due to unexpected saturation of the low-spin signal when using phosphate buffer and scanning at 5 K (rather than 77 K using HEPES buffer, as used by Schwab et al.).
The nitrite reaction with methemoglobin is clearly more complex than suggested by Schwabet al., and we hypothesize that this complexity is related to the predominance and properties of the O-nitrito species.
References
Basu, S. et al. Nat. Chem. Biol. 3, 785–794 (2007).
Dejam, A. et al. Circulation 116, 1821–1831 (2007).
Cosby, K. et al. Nat. Med. 9, 1498–1505 (2003).
Kozlov, A.V. et al. Antioxid. Redox Signal. 7, 515–521 (2005).
Tsuchiya, K. et al. Am. J. Physiol. Heart Circ. Physiol. 288, H2163–H2170 (2005).
Tsuchiya, K. et al. J. Pharmacol. Sci. 96, 395–400 (2004).
Hunter, C.J. et al. Nat. Med. 10, 1122–1127 (2004).
Webb, A. et al. Proc. Natl. Acad. Sci. USA 101, 13683–13688 (2004).
Maher, A.R. et al. Circulation 117, 670–677 (2008).
Webb, A.J. et al. Hypertension 51, 784–790 (2008).
Larsen, F.J., Ekblom, B., Sahlin, K., Lundberg, J.O. & Weitzberg, E. N. Engl. J. Med. 355, 2792–2793 (2006).
Yi, J., Safo, M.K. & Richter-Addo, G.B. Biochemistry 47, 8247–8249 (2008).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
R.P., M.T.G. and D.B.K.-S. are named as co-inventors on US National Institutes of Health patent applications for the use of (i) nitrite salts in the treatment of cardiovascular diseases and (ii) nitrite–methemoglobin as a blood substitute.
Rights and permissions
About this article
Cite this article
Goetz, B., Wang, P., Shields, H. et al. Reply to 'Nitrite–methemoglobin inadequate for hypoxic vasodilation'. Nat Chem Biol 5, 367 (2009). https://doi.org/10.1038/nchembio0609-367
Issue Date:
DOI: https://doi.org/10.1038/nchembio0609-367